Show simple item record

dc.contributor.authorPhilipson, Tomas J.
dc.contributor.authorvon Eschenbach, Andrew C.
dc.contributor.authorLo, Andrew W
dc.date.accessioned2017-05-15T14:13:31Z
dc.date.available2017-05-15T14:13:31Z
dc.date.issued2015-10
dc.identifier.issn2374-2437
dc.identifier.issn2374-2445
dc.identifier.urihttp://hdl.handle.net/1721.1/109078
dc.description.abstractAmericans are increasingly apprehensive about our future, so it is inspiring when Congress produces legislation intended to both enhance our health and expand our economy. The 21st Century Cures Act,1 recently passed by the House with an impressive bipartisan majority vote of 344 to 77, intends to accelerate the many-step process of drug discovery and development, from basic scientific research to clinical development to delivery, distribution, and ongoing monitoring. Among other things, the legislation boosts National Institute of Health funding, dramatically speeds up the US Food and Drug Administration (FDA) approval process, and aims to make use of new information technology to better monitor the performance of medical products after they reach the market. This landmark bill now awaits a comparable piece of legislation being developed by the Senate Health Education, Labor, and Pensions Committee. Together, they will transform the biomedical ecosystem and provide the foundation for the next several decades of innovative life-saving and health-enhancing solutions for our nation and the world.en_US
dc.language.isoen_US
dc.relation.isversionofhttp://dx.doi.org/10.1001/jamaoncol.2015.4221en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourceMIT Web Domainen_US
dc.titleHealth, Wealth, and the 21st Century Cures Acten_US
dc.typeArticleen_US
dc.identifier.citationLo, Andrew W.; Philipson, Tomas J. and von Eschenbach, Andrew C. “Health, Wealth, and the 21st Century Cures Act.” JAMA Oncology 2, no. 1 (January 2016): 17.en_US
dc.contributor.departmentSloan School of Managementen_US
dc.contributor.mitauthorLo, Andrew W
dc.relation.journalJAMA Oncologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsLo, Andrew W.; Philipson, Tomas J.; von Eschenbach, Andrew C.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-2944-7773
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record